Efficacy and safety of everolimus treatment in metastatic renal cell carcinoma Comment uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Clinical Trials as Topic
  • Kidney Neoplasms

abstract

  • Everolimus was effective in Korean patients with mRCC who had failed initial VEGFr-TKI therapy. While everolimus was well tolerated in general and the AE incidence of this study was similar to those of previous reports, severe pneumonitis was common. Hyperglycemia and anemia showed significant correlation with PFS and thus may be potentially useful as prognostic indicators.

publication date

  • April 2009

Research

keywords

  • Comment

Additional Document Info

start page

  • 339

end page

  • 47

volume

  • 8

number

  • 4